An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial.
from Top Health News – ScienceDaily http://ift.tt/2zBQXvY
from Tumblr http://ift.tt/2AKujW6
No comments:
Post a Comment